NCT05256108

Phase 1Interventional

Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.

View on ClinicalTrials.gov ↗

Timeline

Start date: Mar 28, 2022
Primary completion: Jul 12, 2022
Completion date: Jul 12, 2022
First posted: Feb 25, 2022
Last posted: Jul 27, 2022
Enrollment: 38
Arms / groups: 5 / —
Source: AACT · ctgov ingestion

Drugs studied

cebranopadol
oxycodone
tramadol

Indications studied

Substance Abuse, Oral

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.

NCT05256108

Timeline

Sponsors

Drugs studied

Indications studied